Who invested in Nectero Medical

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$96Mraised across 1 round since 2024, from 1 source

Latest round: Series D, $96MApr 2024
Investors: 2

See who backed them

The rounds

Apr 2024
Series D$96M
- Alumni Ventures
- Norwest Venture Partners
Source recordedSEC filing: $33M sold, first sale Apr 2024

Founders and team

From Nectero Medical's own website and the SEC filings it signed: 10 on the team.

Charlene KnapeVice President – Clinical Affairs
Julie-Lea LipszycVice President – Quality
Kathleen HessVice President – Development and Program Management
Jack SpringerPresident & CEO
Jack MiceliChief Financial Officer
Bryan ZieglerChief Financial Officeri
Anil DasuBoard Member
Bruce RobertsBoard Member
Colin MorrisonBoard Member
Robert WhirleyChairman

Everyone who backed them

Alumni VenturesVC firm1round

Norwest Venture PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Nectero Medical as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.